HUMANISIERTE ODER CHIMÄRE CD3-ANTIKÖRPER

European patent · EP3322727 · In force

Register entry

Publication number
EP3322727
Application number
EP16739459
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 14, 2016
Published
May 23, 2018
Granted
Dec 31, 2025
Protection ends at the latest
Jul 13, 2036
Next annual fee due
Jul 31, 2027
IPC classes
C07K 16/28 (2006.01)
C07K 16/32 (2006.01)
Priority
DK 201500414 15.07.2015
DK 201500413 15.07.2015
DK 201500416 16.07.2015
WO PCT/EP2016/050296 08.01.2016
PCT application
PCT/EP2016/066845 14.07.2016
PCT publication
WO2017/009442 19.01.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Feb 13, 2026

    Agent entered

    Representative
    OFFICE FREYLINGER S.A., c/o Schluep IP Law AG, Falkenplatz 7, 3012 Bern

    Published in Swissreg on 13.02.2026

  3. Dec 31, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 31.12.2025

Parties

Holder

Genmab A/S

Carl Jacobsens Vej 30, 2500 Valby, DK

Agent

OFFICE FREYLINGER S.A. c/o Schluep IP Law AG

Falkenplatz 7, 3012 Bern

Inventor

RADEMAKER, Rik

3584 CT Utrecht, NL

ALTINTAS, Isil

3584 CT Utrecht, NL

ENGELBERTS, Patrick

3584 CT Utrecht, NL

SCHUURMAN, Janine

1111 CH Diemen, NL

PARREN, Paul

3984 PR Odijk, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.